Small study shows association between medication and reduction in brain amyloid levels related to AD

Although it is a small study and more clinical trials are needed, treatment with the medication gantenerumab appeared to result in a reduction in brain amyloid levels in patients with Alzheimer disease, according to a report published Online First by Archives of Neurology.

Read the whole article on Physorg

More from Physorg